A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma
Condition(s):Diffuse Large B-cell LymphomaLast Updated:April 1, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B-cell LymphomaLast Updated:April 1, 2021Unknown status
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:March 26, 2024Recruiting
Condition(s):Diffuse Large B-cell LymphomaLast Updated:December 10, 2020Unknown status
Condition(s):Relapsed or Refractory Diffuse Large B-cell LymphomaLast Updated:October 11, 2023Active, not recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:June 9, 2020Unknown status
Condition(s):Diffuse Large B Cell Lymphoma,DLBCLLast Updated:January 19, 2024Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:March 5, 2024Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:August 31, 2022Recruiting
Condition(s):Relapsed Diffuse Large B-cell LymphomaLast Updated:November 1, 2023Withdrawn
Condition(s):Relapsed Diffuse Large B-cell Lymphoma; Refractory Diffuse Large B-cell LymphomaLast Updated:November 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.